The Cardiac Infarction Injury Score (CIIS) is an electrocardiographic classification system that was developed as a diagnostic tool to assess the extent of cardiac injury in acute myocardial infarction. We investigated the prognostic value of the CIIS in post-myocardial infarction patients.
Introduction
Post-myocardial infarction risk assessment may be based upon non-invasive as well as invasive tests, which address various aspects of myocardial damage or residual cardiac function [1, 2] . The Cardiac Infarction Injury score (CIIS) is an electrocardiographic measurement which was constructed as a diagnostic tool to assess the extent of cardiac injury in myocardial infarction and to discriminate between the presence or absence of a recent myocardial infarction [3] . Selected electrocardiographic characteristics are weighted and combined into a single score. Subjects with a high CIIS score are likely to have had a (larger) myocardial infarction. As this score is weighted upon different elements of the ECG (including Q waves and T waves), it might be more reliable in larger groups of patients than single ECG markers.
A limited number of studies assessed the prognostic value of the CIIS in healthy populations [4, 5] and hypertensive patients [6, 7] . The present study addressed the prognostic value of the CIIS in postmyocardial infarction patients. The aim was to determine the independent contribution of the CIIS to the risk of total mortality, cardiac mortality and reinfarction in a large series of patients (n=3395), who were enrolled in the Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) trial [8] .
Methods

Patients
Patients were enrolled in ASPECT from September 1986 until December 1991. ASPECT was a multicentre, randomized, double-blind trial, with two treatment arms: 'active' anticoagulant therapy and matching placebo [8] . The diagnosis of myocardial infarction was based upon (1) chest pain (2) typical serum enzyme pattern and (3) evolving ST-T segment and/or Q waves. Exclusion criteria included established indications for anticoagulant treatment (e.g. left ventricular thrombus, aneurysm, extensive left ventricular dysfunction and chronic atrial fibrillation), anticoagulant therapy within 6 months prior to the index infarction, increased bleeding tendency, anticipated coronary revascularization procedure and malignant disease with poor prognosis. All patients were followed for 37 (6-67) months. Design, patient selection, data acquisition, data management and follow-up of ASPECT have been reported previously [8] .
Data acquisition
Before randomization, a set of demographic and historical variables was collected on each patient: age, sex, prior myocardial infarction, current smoking habits, diabetes, prior revascularization, history of angina, location of the infarction, thrombolytic therapy and heart failure defined as Killip class III or IV on admission. In addition, information on the clinical course in hospital and subsequent major clinical events was collected from hospital discharge letters, at the visits to the Thrombosis Centre and from the treating physician. Standard 12-lead electrocardiograms, recorded prior to hospital discharge were coded according to the Minnesota Code (MC) [9] and the CIIS. Twelve ECG features were used to compute the CIIS: five T-wave amplitude measurements; four Q-wave duration measurements or Q/R-amplitude ratios; and three R-or S-amplitude measurements (see appendix). In 3395 out of 3404 patients in ASPECT a 12-lead electrocardiogram was coded. Coding of nine electrocardiograms was not possible.
Major events during follow-up were cardiac death (sudden death, fatal myocardial reinfarction, congestive heart failure), non-cardiac death and myocardial reinfarction (non-fatal or fatal).
Data analysis
The CIIS was originally developed to detect myocardial infarction [3] and was categorized as <10 (no infarction), 10-20 (possible infarction), 20 or more (probable infarction). In this study population all patients had sustained a myocardial infarction. Therefore, we also classified the patients in (higher) cohorts of 10 in the following four categories of the CIIS: (I) less than 20, (II) 20-30, (III) 30-40 and (IV) d40. This resulted in three groups of approximately equal size and one group (IV) which was a third the size of the other groups. Overall, betweengroup differences of baseline characteristics were tested using the Tukey-Cramer method, which adjust for multiple comparisons. End-points are presented as total mortality, cardiac mortality and a combined endpoint of mortality and reinfarction. The probability of these end-points is presented as Kaplan-Meier curves [10] . Differences between curves were analysed with logrank tests [11] . The association of the CIIS with cardiac mortality, total mortality and mortality or non-fatal reinfarction was analysed using Cox proportional hazards models [12] and presented as hazard ratios. Since the prevalence of electrocardiographic abnormalities increases with age, all univariable analyses included age to adjust for possible confounding. To investigate whether the prognostic value of the CIIS was modified by duration of follow-up, we calculated hazard ratios at 6-months, at 1-year and at 3-year follow-up. In the multivariable models, hazard ratios were adjusted for the baseline characteristics as described in the data acquisition section, and for possible confounding and interaction factors. Proportional hazard assumptions were verified by inspection of log-log survival curves.
The predictive value of each component of the CIIS was evaluated by including all 12 items separately in a multivariable model. To evaluate whether the predictive value of the CIIS was independent of the binary ECG abnormalities as used in the Minnesota code, we excluded the following ECG abnormalities one at a time: ST segment depression (Minnesota 4), negative or flat T wave (Minnesota 5), AV conduction defect (Minnesota 6), left ventricular hypertrophy (Minnesota 3-3), premature atrial complex (Minnesota 8-1·1), premature ventricular complex (Minnesota 8·1-2·3), atrial fibrillation (Minnesota 8-3·1) or any arrhythmias (Minnesota any 8 code). Finally, we excluded all patients with any mentioned ECG abnormality.
Results
Of the 3395 patients 80% were male and the mean age was 61 years (range 24 to 89). Mortality in this patient cohort was relatively low. After 3-years follow-up there were 359 deaths (11%), of which 79% were cardiac. The cumulative 6-months and 1-year mortality rates were 2·8% and 4·1%, respectively. Reinfarction occurred in 356 patients (11%) at 3 years and mortality or reinfarction occurred in 618 patients (18%). The mean CIIS was 26 (range 8 to 59). CIIS scores between 20-30 were observed in 29%, CIIS between 30-40 in 31%, and the highest scores (40 or more) in 11% of the patients. The sensitivity of CIIS d20 to confirm the index infarction was 72%. Table 1 shows the distribution of baseline characteristics in the four CIIS categories. Patients with
The Cardiac Infarction Injury Score 1035 a CIIS of 40 or more were older compared to the other three groups. Previous infarction, anterior location of the infarct, heart failure and late ventricular tachycardia/ventricular fibrillation were found more frequently with increasing CIIS, and such patients received more frequent thrombolytic therapy. At discharge of the index infarction, the use of beta-blocking agents was lower but digitalis and diuretics higher with increasing CIIS. Of the ECG abnormalities based upon the Minnesota codes, heart rate d70 beats . min 1 , Q wave, and negative or flat T wave were more frequent in the highest CIIS category, while other ECG characteristics were equally divided over the CIIS categories.
Mortality rates in CIIS categories II-IV were significantly higher than the CIIS category I (Figs 1  and 2 ). Patients with a CIIS <20 had a lower risk of death or reinfarction than the other three CIIS categories (Fig. 3) . Age-adjusted and multivariable adjusted hazards ratios of total and cardiac mortality for several binary ECG criteria on the basis of the Minnesota codes are presented in Table 2 . In multivariable analysis only ventricular conduction defects (right and left bundle branch block), premature atrial complexes and arrhythmias were predictive of mortality. In Table 3 , hazard ratios for total mortality and cardiac mortality in CIIS categories at 6 months, 1 year and 3 years are presented. At any moment of follow-up, the hazard ratios demonstrate an increased relative risk for categories II-IV compared to category I. The CIIS categories 30-40 and d40 were independent predictors for short-and long-term total mortality, with relative risks varying, respectively, from 1·5 to 2·0 and from 1·7 to 2·3 for cardiac mortality. The CIIS category 20-30 was predictive for cardiac mortality at 3 years with a relative risk of 1·6, and predictive for total mortality with relative risks of 1·7 (1 year) and 1·5 (3 years). The CIIS was the strongest predictor in the multivariable analyses, even when nine other baseline risk factors were included. The predictive value for 3-year mortality or reinfarction was low with relative risks of 1·31 (95% CI: 1·06-1·62), 1·23 (95% CI: 0·99-1·53) and 1·22 (95% CI: 0·92-1·62) for CIIS categories 20-30, 30-40 and 40 or more, respectively. To evaluate whether the predictive value of the CIIS was independent of the binary ECG abnormalities on the basis of the Minnesota codes, these abnormalities were excluded one category at a time. When patients with any ST segment depression, atrioventricular conduction defect, left or right bundle branch block, left ventricular hypertrophy or any arrhythmias were excluded (data not shown), the relative risks remained significantly higher in the CIIS categories III and IV. When patients with any major Minnesota Codes were excluded, the rates were still 1·5 times higher in class III than class I patients, although this was not significant, and 2·7 times higher in class IV than class I (95% CI: 1·4-5·3).
The relative contribution of each of the 12 CIIS items were separately analysed. The amplitudes of R (item 3, see Appendix) and negative T in aVR (item 4) as well as the amplitude of positive T in V 1 (item 8) and Q duration in lead III or AVL (item 6) are significant components of the CIIS for total mortality, and most of the same items were predictive of cardiac mortality (with the negative T amplitude in lead V 2 (item 9) replacing item 6). The relative risk for mortality remained unchanged when patients with an anterior infarction or patients with a prior infarction were excluded. Inclusion of other possible confounding factors into the models did not change the associations. Analyses performed separately in both the anticoagulant and placebo groups had similar results.
Discussion
Infarct size is an important predictor of long-term mortality, whether measured by myocardial enzyme release [1, 2] , global or regional left ventricular function or estimated by exercise capacity [13] . The CIIS is a simple and inexpensive measurement of infarct size from the 12-lead ECG, and Willems et al. [14] confirmed that it reflected myocardial infarct size in acute myocardial 
The Cardiac Infarction Injury Score 1037
infarction patients. The CIIS has been applied in healthy and hypertensive subjects [47] , in whom it appeared to be of prognostic value for long-term mortality.
To our knowledge, this is the first report to investigate the prognostic value of the CIIS in terms of mortality in post-myocardial infarction, and confirms that this scoring system, composed of 12 items from the 12-lead ECG made at discharge in myocardial infarction survivors, is an important predictor of mortality during long-term follow-up. The CIIS has been developed from a well validated database [3] by an extensive statistical search for the best combination of variables and was originally designed to increase the sensitivity of the detection of a recent myocardial infarction (50% infarctions <1 month; 50%: between 1 month and 1 year). Other studies have investigated the ECG QRS scoring system for prediction of an acute or recent infarction [14, 15] . However, only Bounus et al. [16] investigated the predicted value of long-term outcome in patients with coronary artery disease, but he was unable to predict the independent prognostic value of the QRS score. In previous studies [3] [4] [5] [6] , high CIIS was associated with increased mortality. In hypertensive men in the MRFIT trial [6] a CIIS of 10 or more was associated with coronary heart disease mortality in the intervention group. Dekker et al. [5] reported an association of CIIS >20 with coronary heart disease mortality among apparently healthy middle-aged Dutch civil servants. They also found that CIIS >10 was a predictor of cardiac mortality in apparently healthy men and women. During follow-up in the present study an increasing mortality rate was found with increasing CIIS. The predictive value of the CIIS for mortality was highest after 1 year and decreased with prolonged follow-up, but remained a strong predictor for mortality at 3 years. The CIIS had no predictive value for reinfarction (fatal or non-fatal), and only a >40 predictive value could be shown for short-and long-term prognosis for the combined end-point of mortality and myocardial reinfarction.
The data indicate that the CIIS, calculated at discharge of post-myocardial infarction patients, is directly related to the risk of subsequent mortality. There was a modest increase in risk associated with a higher score, which was independent of other clinical characteristics and conventional ECG criteria. For this reason, analyses based upon binary ECG criteria using the Minnesota codes may underestimate the importance of these pathophysiological abnormalities as potential determinants of mortality. The findings suggest that not only the presence but also the severity of abnormalities of cardiac structures and electrophysiological function account, in part, for the increased risk of mortality, observed among post-myocardial infarct patients.
Limitations
The study population was selected from a trial excluding patients with a large myocardial infarction. Only 24% of the patients had an anterior myocardial infarction and the mortality rate was low. This resulted in a low-risk group of post-infarct patients. Nevertheless, it is remarkable that even in this study population, risk assessment with the CIIS was successful. Verification and extension of these data in post-infarction patients at similar or higher risk is warranted.
Conclusion
The standard 12-lead ECG is an important and basic tool for risk stratification of post-myocardial infarction. By maximizing the prognostic information from the standard ECG in a simple quantitative fashion, the CIIS ECG system appears to be a useful instrument for clinicians who treat long-term post-myocardial infarction patients. The CIIS can easily be automated and by simple quantification, important prognostic risk assessments can be made. The possibility to predict long-term survival or early mortality provides an opportunity for planning adequate surveillance and diagnostic and interventional programmes. Although these results suggest that the CIIS may be a better predictor than the traditional binary ECG criteria that are used to assess myocardial damage, clinicians should be aware that both the sensitivity of the CIIS and the increase in absolute risk remain modest.
